The chronic weight management market is at an inflection point. Analysts have forecast that sales of weight-loss drugs could potentially hit 100 billion US dollars by 2030, buoyed by promising results in recent clinical trials. We speak to Michael Shah, Senior Equity Research Analyst at Bloomberg Intelligence for insights into this growing market.  

Image credit: Shutterstock.com